Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoping Su

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Cell Reports|October 18, 2018
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell OntogenyMarion Classe, Hui Yao, Roger Mouawad, et al.
Neoplasia (New York, N.Y.)|November 23, 2024
Depletion of regulatory T cells enhances the T cell response induced by the neoantigen vaccine with weak immunogenicityRuichen Huang, Qiao Zhou, Jiajun Liu, et al.
Blood Cancer Journal|February 5, 2024
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)Christopher P Mill, Warren C Fiskus, Courtney D DiNardo, et al.
Cell Reports|September 1, 2024
Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironmentZhiwen Luo, Jie Mei, Xianwen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2013
Genomic heterogeneity of translocation renal cell carcinomaGabriel G Malouf, Federico A Monzon, Jérôme Couturier, et al.
Leukemia|March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
Frontiers in Immunology|September 25, 2023
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancerBrandon Mistretta, Sakuni Rankothgedera, Micah Castillo, et al.
Cancer Discovery|April 17, 2023
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic ProgramJovanka Gencel-Augusto, Xiaoping Su, Yuan Qi, et al.
European Urology|February 21, 2016
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic AlterationsGabriel G Malouf, Siraj M Ali, Kai Wang, et al.
Cancer Immunology Research|April 26, 2014
PD-L1 expression in triple-negative breast cancerElizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Cell Reports|October 18, 2018
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell OntogenyMarion Classe, Hui Yao, Roger Mouawad, et al.
Neoplasia (New York, N.Y.)|November 23, 2024
Depletion of regulatory T cells enhances the T cell response induced by the neoantigen vaccine with weak immunogenicityRuichen Huang, Qiao Zhou, Jiajun Liu, et al.
Blood Cancer Journal|February 5, 2024
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)Christopher P Mill, Warren C Fiskus, Courtney D DiNardo, et al.
Cell Reports|September 1, 2024
Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironmentZhiwen Luo, Jie Mei, Xianwen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2013
Genomic heterogeneity of translocation renal cell carcinomaGabriel G Malouf, Federico A Monzon, Jérôme Couturier, et al.
Leukemia|March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
Frontiers in Immunology|September 25, 2023
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancerBrandon Mistretta, Sakuni Rankothgedera, Micah Castillo, et al.
Cancer Discovery|April 17, 2023
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic ProgramJovanka Gencel-Augusto, Xiaoping Su, Yuan Qi, et al.
European Urology|February 21, 2016
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic AlterationsGabriel G Malouf, Siraj M Ali, Kai Wang, et al.
Cancer Immunology Research|April 26, 2014
PD-L1 expression in triple-negative breast cancerElizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.
Pageof 20